For instance, evaluating charged ADCs in HER2-low or HER2-negative tumors would clarify whether nonspecific pinocytosis meaningfully contributes to tumor accumulation when receptor-mediated internalization is limited. This evidence concerns the gene ERBB2 and neoplasm.